Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;12(2):283-297.
doi: 10.34172/apb.2022.029. Epub 2021 May 30.

Bioorganometallic Compounds as Novel Drug Targets against Schistosomiasis in Sub-Saharan Africa: An alternative to Praziquantel?

Affiliations
Review

Bioorganometallic Compounds as Novel Drug Targets against Schistosomiasis in Sub-Saharan Africa: An alternative to Praziquantel?

Cuma Cumisa Ndamse et al. Adv Pharm Bull. 2022 Mar.

Abstract

Human schistosomiasis is a disease that mostly plagues the destitute of various tropical and sub-tropical countries, particularly in sub-Saharan Africa (SSA) and South America. It has significant effects on various health and economic-related matters. Globally, the burden of schistosomiasis has been controlled with a single chemotherapeutic drug, praziquantel (PZQ), which has recently demonstrated several clinical issues, including its inability to destroy juvenile schistosome worms and drug resistance because of its extensive use. The use of organometallic moieties in biological and medicinal chemistry has developed greatly and has led to their use in various anti-cancer and anti-infectious agents. The abundance of a range of organometallic compounds that can cause damage to the parasite has received tremendous feedback, with many already at clinical trials. The distinct redox biology of the schistosome parasite is a vulnerable element to the survival of the worm and has steered attempts toward the use of redox-directed bioorganometallic compounds. Disruption of the schistosome redox homeostasis through organometallic ions provides a novel drug target that could be used in overcoming the drawbacks of the mainstream drug and one that could possibly bypass the emergence of drug resistance.

Keywords: Bioorganometallic compounds; Praziquantel; Reactive oxygen species; Redox biology; Schistosoma mansoni; Schistosomiasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3

References

    1. Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383(9936):2253–64. doi: 10.1016/s0140-6736(13)61949-2. - DOI - PMC - PubMed
    1. Costain AH, MacDonald AS, Smits HH. Schistosome egg migration: mechanisms, pathogenesis and host immune responses. Front Immunol. 2018;9:3042. doi: 10.3389/fimmu.2018.03042. - DOI - PMC - PubMed
    1. Zhou L, Yu L, Wang Y, Lu Z, Tian L, Tan L. et al. A hybrid model for predicting the prevalence of schistosomiasis in humans of Qianjiang city, China. PLoS One. 2014;9(8):e104875. doi: 10.1371/journal.pone.0104875. - DOI - PMC - PubMed
    1. Ishida K, Jolly ER. Hsp70 may be a molecular regulator of schistosome host invasion. PLoS Negl Trop Dis. 2016;10(9):e0004986. doi: 10.1371/journal.pntd.0004986. - DOI - PMC - PubMed
    1. Masamba P, Adenowo AF, Oyinloye BE, Kappo AP. Universal stress proteins as new targets for environmental and therapeutic interventions of schistosomiasis. Int J Environ Res Public Health. 2016;13(10):972. doi: 10.3390/ijerph13100972. - DOI - PMC - PubMed

LinkOut - more resources